Expression of Matrix Metalloproteinase-9 in Gastric Cancer
- PMID: 34707964
- PMCID: PMC8536001
- DOI: 10.7759/cureus.18195
Expression of Matrix Metalloproteinase-9 in Gastric Cancer
Abstract
Background Matrix-metalloproteinase-9 (MMP-9) is expressed by a wide range of cells and plays a significant role in the regulation of the tumor microenvironment of various cancers including gastric cancer. This study aims at the correlation of MMP-9 expression in gastric cancer with existing prognostic factors. Methods The MMP-9 expression in gastric cancer was identified by immunohistochemistry using a monoclonal antibody in paraffin-embedded sections, correlated with various clinicopathological parameters, and statistically analyzed. Results MMP-9 expression in gastric cancer was significantly correlated with the grade, depth of invasion, and TNM stage (p-value = 0.003, 0.019, and 0.025, respectively). A significant difference in expression between tumor tissue and adjacent gastric mucosa (p-value = 0.000) was also observed. 100% negative expression was found in well-differentiated tumors and early gastric carcinoma (T1). Conclusion The study results suggest that MMP-9 expression could be a potential biomarker of aggressive gastric cancer and candidates for the possible diagnostic and prognostic tool.
Keywords: biomarker; collagenase; gastric cancer; matrix-metalloproteinase; mmp-9.
Copyright © 2021, R et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures

References
-
- Estimates of the worldwide incidence of eighteen major cancers in 1985. Parkin DM, Pisani P, Ferlay J. Int J Cancer. 1993;54:594–606. - PubMed
-
- Rising incidence of adenocarcinoma of the esophagus and gastric cardia. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. https://pubmed.ncbi.nlm.nih.gov/1995976/ JAMA. 1991;265:1287–1289. - PubMed
-
- Epidemiologic trends in esophageal and gastric cancer in the United States. Brown LM, Devesa SS. Surg Oncol Clin N Am. 2002;30:235–256. - PubMed
-
- Global cancer statistics, 2012. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. CA Cancer J Clin. 2015;65:87–108. - PubMed
-
- Comparison of extracellular matrix-degrading activities between 64-kDa and 90-kDa gelatinases purified in inhibitor-free forms from human schwannoma cells. Yasumitsu H, Miyazaki K, Umenishi F, Koshikawa N, Umeda M. J Biochem. 1992;111:74–80. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous